BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 26999661)

  • 1. Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy.
    Cao AL; Wang L; Chen X; Wang YM; Guo HJ; Chu S; Liu C; Zhang XM; Peng W
    Lab Invest; 2016 Jun; 96(6):610-22. PubMed ID: 26999661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy.
    Tian N; Gao Y; Wang X; Wu X; Zou D; Zhu Z; Han Z; Wang T; Shi Y
    Drug Des Devel Ther; 2018; 12():2195-2211. PubMed ID: 30034224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress.
    Cao A; Wang L; Chen X; Guo H; Chu S; Zhang X; Peng W
    Biol Pharm Bull; 2016 Aug; 39(8):1300-8. PubMed ID: 27193377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
    Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
    Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.
    Guo H; Wang Y; Zhang X; Zang Y; Zhang Y; Wang L; Wang H; Wang Y; Cao A; Peng W
    Sci Rep; 2017 Jul; 7(1):6852. PubMed ID: 28761152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress.
    Wu L; Wang Q; Guo F; Ma X; Wang J; Zhao Y; Yan Y; Qin G
    J Cell Physiol; 2021 Feb; 236(2):1454-1468. PubMed ID: 32691413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities.
    Guo C; Liu Y; Zhao W; Wei S; Zhang X; Wang W; Zeng X
    J Cell Mol Med; 2015 Sep; 19(9):2273-85. PubMed ID: 26103809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats.
    Chen Y; Gui D; Chen J; He D; Luo Y; Wang N
    Cell Physiol Biochem; 2014; 33(6):1975-87. PubMed ID: 25012492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow.
    Chung J; Kim KH; Lee SC; An SH; Kwon K
    Mol Cells; 2015 Oct; 38(10):851-8. PubMed ID: 26442866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rtn1a-Mediated Endoplasmic Reticulum Stress in Podocyte Injury and Diabetic Nephropathy.
    Fan Y; Zhang J; Xiao W; Lee K; Li Z; Wen J; He L; Gui D; Xue R; Jian G; Sheng X; He JC; Wang N
    Sci Rep; 2017 Mar; 7(1):323. PubMed ID: 28336924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis.
    Vilatoba M; Eckstein C; Bilbao G; Smyth CA; Jenkins S; Thompson JA; Eckhoff DE; Contreras JL
    Surgery; 2005 Aug; 138(2):342-51. PubMed ID: 16153446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase 5 contributes to endoplasmic reticulum stress induced podocyte apoptosis via promoting MEKK1 phosphorylation at Ser280 in diabetic nephropathy.
    Zhang Y; Gao X; Chen S; Zhao M; Chen J; Liu R; Cheng S; Qi M; Wang S; Liu W
    Cell Signal; 2017 Feb; 31():31-40. PubMed ID: 28024901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of calcineurin in podocytes in response to endoplasmic reticulum stress in diabetic nephropathy].
    Hu RR; Ma J; Tao JL; Wen YB; Zhao C; Zhang W; Li H; Li MX; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):477-81. PubMed ID: 25360643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy.
    Huang SS; Ding DF; Chen S; Dong CL; Ye XL; Yuan YG; Feng YM; You N; Xu JR; Miao H; You Q; Lu X; Lu YB
    Sci Rep; 2017 Apr; 7():45692. PubMed ID: 28374806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arctigenin ameliorates renal impairment and inhibits endoplasmic reticulum stress in diabetic db/db mice.
    Zhang J; Cao P; Gui J; Wang X; Han J; Wang Y; Wang G
    Life Sci; 2019 Apr; 223():194-201. PubMed ID: 30898648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.